Article
Longitudinal Assessment of Cognitive Development in 23 Patients With Mucopolysaccharidosis (MPS) Type II: Results of up to 14 Years of Follow-Up.
Journal of inherited metabolic disease - 1 Sept 2026
Holdorp J Julia, Kruijshaar M E Michelle, Vollebregt A A M Audrey, Rietman A B Andre, Dijkstra M R K Marianne, Klees C Carina, Wagenmakers M Margreet, Nguyen A H P Annie, Oussoren E Esmee, van der Ploeg A T Ans, van den Hout J M P Hannerieke
Abstract excerpt
This study investigated long-term cognitive development and genotype-phenotype relationships in patients with Mucopolysaccharidosis Type II (MPS II). A nationwide prospective cohort study was conducted in the Netherlands with cognitive follow-up since 2007. Patients were classified as neuronopathic or non-neuronopathic based on iduronate-2-sulphatase (IDS) genotype; novel variants based on age and intelligence...
Read the complete abstract on PubMedTopics
- Humans
- Mucopolysaccharidosis II
- Male
- Child
- Child, Preschool
